| pubmed-article:12380723 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12380723 | lifeskim:mentions | umls-concept:C2922974 | lld:lifeskim |
| pubmed-article:12380723 | lifeskim:mentions | umls-concept:C0030231 | lld:lifeskim |
| pubmed-article:12380723 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:12380723 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:12380723 | pubmed:dateCreated | 2002-10-16 | lld:pubmed |
| pubmed-article:12380723 | pubmed:abstractText | Minimising polypharmacy is important A study was done to see if this was achievable in patients under palliative care and compares the types of drugs used before and after referral. | lld:pubmed |
| pubmed-article:12380723 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12380723 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12380723 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12380723 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12380723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12380723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12380723 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12380723 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12380723 | pubmed:issn | 0037-5675 | lld:pubmed |
| pubmed-article:12380723 | pubmed:author | pubmed-author:KopW AWA | lld:pubmed |
| pubmed-article:12380723 | pubmed:author | pubmed-author:DobD PDP | lld:pubmed |
| pubmed-article:12380723 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12380723 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:12380723 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12380723 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12380723 | pubmed:pagination | 279-83 | lld:pubmed |
| pubmed-article:12380723 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12380723 | pubmed:meshHeading | pubmed-meshheading:12380723... | lld:pubmed |
| pubmed-article:12380723 | pubmed:meshHeading | pubmed-meshheading:12380723... | lld:pubmed |
| pubmed-article:12380723 | pubmed:meshHeading | pubmed-meshheading:12380723... | lld:pubmed |
| pubmed-article:12380723 | pubmed:meshHeading | pubmed-meshheading:12380723... | lld:pubmed |
| pubmed-article:12380723 | pubmed:meshHeading | pubmed-meshheading:12380723... | lld:pubmed |
| pubmed-article:12380723 | pubmed:meshHeading | pubmed-meshheading:12380723... | lld:pubmed |
| pubmed-article:12380723 | pubmed:meshHeading | pubmed-meshheading:12380723... | lld:pubmed |
| pubmed-article:12380723 | pubmed:meshHeading | pubmed-meshheading:12380723... | lld:pubmed |
| pubmed-article:12380723 | pubmed:meshHeading | pubmed-meshheading:12380723... | lld:pubmed |
| pubmed-article:12380723 | pubmed:meshHeading | pubmed-meshheading:12380723... | lld:pubmed |
| pubmed-article:12380723 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12380723 | pubmed:articleTitle | Polypharmacy in palliative care: can it be reduced? | lld:pubmed |
| pubmed-article:12380723 | pubmed:affiliation | Department of General Medicine, Tan Tock Seng Hospital, Singapore. kohnienyue@yahoo.com.sg | lld:pubmed |
| pubmed-article:12380723 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12380723 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12380723 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12380723 | lld:pubmed |
